+ T cells are a principal component of immunity against intracellular pathogens such as viruses. They are distinguished by their capacity to survive long term, undergo rapid and robust proliferation and acquire effector function upon antigen re-exposure
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Memory CD8
+ T cells can vary in their phenotype, localization and function, allowing them to protect the host against a broad array of potential insults. CD8 + T cells can mediate the killing of infected cells through many mechanisms, including the expression of granzymes and perforin, and the secretion of cytokines such as interferon-γ (IFNγ) and tumour necrosis factor (TNF). Unlike neutralizing antibodies that largely recognize proteins expressed on pathogen surfaces, CD8 + T cells respond to peptide sequences presented on the surface of antigen-presenting cells. This allows them to recognize internal proteins of the pathogen that are less subject to evolutionary pressure and thus tend to be more highly conserved between different pathogen vari ants than external pathogen proteins. Therefore, CD8 + T cells have the potential to provide broadly reactive protection against viruses, such as influenza virus or HIV, that rapidly mutate their surface proteins 2 . Despite the use of memory CD8 + T cells in protection against pathogens that rapidly mutate to elude neutralizing antibodies, the development of T cell-based vaccines has proved to be problematic 3 . This failure is largely due to an incomplete understanding of the signals and cell types that operate at different stages of the immune response to influence the quantity and quality of developing memory CD8 + T cells. In addition, knowledge of how CD8 + T cells are able to enter and maintain residence in mucosal tissues is of crucial importance as many of the infections to which effective vaccines have not been developed initially infect mucosal sites such as the lungs, reproductive tract and skin. To generate a protective memory CD8 + T cell response, it is important to understand the signals that are needed to position the memory T cells at the initial site of infection, as well as to induce a circulating memory pool that can prevent outgrowth of the pathogen.
The T cell response to acute infection can typically be divided into three phases -priming and expansion, resolution and contraction, and memory. During the first phase, naive CD8 + T cells divide and differentiate into effector T cells that acquire the ability to produce IFNγ, TNF and cytotoxic proteins such as granzymes and perforin 4 . Following viral clearance, the contraction and resolution phase ensues, in which the majority of the effector CD8 + T cells die, with ~5-10% of cells surviving. These cells enter the third stage -the 'memory' phase -and are maintained long term by signals such as interleukin-7 (IL-7) and IL-15 (REF. 5 ). Although there is considerable heterogeneity among long-lived CD8 + T cells, they are typically divided into tissue-resident memory (T RM ), effector memory (T EM ) and central memory (T CM ) T cells. Differences in their localization, recall ability and effector functions allow them to provide overlapping layers of protection against potential reinfection 6 . T RM cells are located in mucosal sites, such as the lungs, skin and reproductive tract, and are unique among memory T cell populations in that they do not re-enter the circulation. They are characterized by high expression of CD69 and CD103 (also known as αE integrin) and act as sentinels to provide immediate protection upon local secondary infection through direct effector functions and the recruitment 1, 2 , Joseph E. Craft 1, 3 and Susan M. Kaech 1, 4 Abstract | Following infection, T cells differentiate into a heterogeneous population of effector T cells that can mediate pathogen clearance. A subset of these effector T cells possesses the ability to survive long term and mature into memory T cells that can provide long-term immunity. and reactivation of immune cells [7] [8] [9] [10] [11] [12] . The developmental pathway and function of T RM cells are reviewed elsewhere in this issue (see REF. 13 ). T EM cells can migrate between tissues and secondary lymphoid organs and provide immune surveillance. T EM cells have constitutive expression of some effector functions and lack expression of CD62L (also known as L-selectin) and CC-chemokine receptor 7 (CCR7) 1, 5 . T CM cells reside in secondary lymphoid organs and are typically characterized by expression of CD62L and CCR7, which are needed for entry therein. They possess the greatest proliferative potential among the memory T cell subsets and can rapidly expand and differentiate following re-challenge.
Considerable work over the past decade has sought to elucidate the signalling and transcriptional networks governing CD8 + T cell fate decisions, and these studies have been reviewed recently (see REF. 5 ). This Review focuses on the crucial roles of CD4 + T cells in the develop ment of effector and memory CD8 + T cells [14] [15] [16] [17] [18] [19] [20] . We discuss recent studies that provide mechanistic insight into the process underlying the requirement for
CD4
+ T cells in memory CD8 + T cell maturation and function in different settings. This Review is divided into four main sections that discuss the involvement of CD4 + T cells in CD8 + T cell immunity following immunization or infection with pathogens that cause systemic, mucosal or chronic infections.
+ T cell help following immunization Primary response. Following immunization, CD4 + T cells are necessary for the induction of a robust primary CD8 + T cell response in terms of both cell number and functionality [21] [22] [23] [24] [25] [26] [27] [28] (FIG. 1a) . In addition, CD8 + T cells that differentiate in the absence of CD4 + T cell help are impaired in their long-term survival and display poor proliferative ability following secondary challenge 14, 17, 29, 30 . Considerable work has sought to understand the processes underlying these defects.
A primary mechanism by which CD4 + T cells support the CD8 + T cell response following immunization is through the 'licensing' of dendritic cells (DCs). CD4 + T cell help is required for DCs to increase their antigen-presenting and co-stimulatory capacities to levels that are sufficient to induce a robust effector CD8 + T cell response, with both the CD4 + T cells and CD8 + T cells recognizing antigen presented by the same DC [7] [8] [9] [10] [11] [12] 23 . This licensing is mediated through CD40 (also known as TNFRSF5)-CD40 ligand (CD40L) inter actions between the DC and cognate CD4 + T cell that allow for the functional maturation of DCs 21, 22 . The licensed DCs can subsequently interact with CD8 + T cells and induce a strong primary response 24 . CD40-CD40L interactions can also occur directly between CD8 + T cells and CD4 + T cells in response to cellular antigen 17 , although the functional importance of this interaction in other contexts appears to be minimal 31, 32 .
Cross-presentation

CD4
+ T cells can also support the primary CD8 + T cell response through facilitation of their interaction with DCs. Before antigen encounter, CD8 + T cells in the draining lymph node upregulate the chemokine receptor CCR5. These cells can then migrate towards the site of antigen-specific DC-CD4 + T cell interactions owing to the production of chemokines such as CC-chemokine ligand 3 (CCL3) and CCL4 by the licensed DCs 33 . This guidance of naive CD8
+ T cells provides an explanation for how they can rapidly find their cognate antigenpresenting cell following immunization, despite the low frequency of both of these populations. Licensing of DCs by CD4 + T cells can also facilitate the entry of naive CD8 + T cells into the draining lymph node through expansion of the arteriole feeding the draining lymph node, as well as through enlargement of the draining lymph node itself, although the precise mechanism by which CD4 + T cells regulate this process remains to be determined 34 . Further insight was provided by two recent studies evaluating the spatio-temporal interactions of DCs and cognate T cells 35, 36 . One found that CD4 + T cell activation precedes that of CD8 + T cells and occurs through interactions with migratory DCs 35 . Activated CD4 + T cells upregulate CD40L expression and subsequently license XC-chemokine receptor 1 (XCR1) + DCs, which specialize in cross-presentation and therefore can engage and activate antigen-specific CD8 + T cells 35 . A separate study found that both CD4 + T cells and CD8 + T cells are activated by distinct DC subsets (non-infected and infected DCs, respectively) at separate anatomical locations 36 . These activated T cells then interact with cognate XCR1 + DCs in clusters, which act as the platform by which CD4 + T cell help is provided to the CD8 + T cells 36 . In the future, it will be important to clarify the differences between these and previous works regarding whether CD8 + T cells are activated by distinct DCs before engagement with XCR1 + DCs and whether initial engagement of CD8 + T cells with XCR1 + DCs precedes licensing of these DCs by CD40L-expressing CD4 + T cells or whether these interactions occur simultaneously.
Secondary response. In addition to their role in the primary response, CD4 + T cells are crucial for regulating the size, phenotype and functionality of the memory CD8 + T cell population 14, 17, 27, 29, 30, 37, 38 . One suggested mechanism for this requirement is through the regulation of TNF-related apoptosis-inducing ligand (TRAIL; also known as TNFSF10) 39, 40 . 'Helpless' CD8 + T cells rapidly induce TRAIL expression upon restimulation and undergo activation-induced cell death, although TRAIL deficiency does not seem to rescue secondary responsiveness of helpless cells in all settings 30 . The ability of CD8 + T cells to respond following secondary challenge seems to be imprinted during their initial priming phase 14, 15 , although the provision of IL-15 during vaccination is sufficient to rescue the secondary cytotoxic T lymphocyte response in the absence of CD4 + T cells; this is probably due to IL-15-mediated suppression of the pro-apoptotic molecule BCL-2-associated X protein (BAX) and induction of the anti-apoptotic molecule BCL-XL (also known as BCL2L1) 28, 39 . IL-15 production by antigen-presenting DCs is necessary even in the presence of CD4 + T cells to allow for the secondary responsiveness of CD8 + T cells 28 . These studies suggest a model in which DCs gain the ability to secrete IL-15 following CD4 + T cell-mediated licensing. IL-2 is also important during priming to imprint the secondary responsiveness of CD8 + T cells 41, 42 . CD4 + T cells have been suggested as a key source of IL-2 (REFS 26, 27, 43, 44) , although other studies have found that CD8 + T cells produce the IL-2 that is necessary for their own development 45 , with licensed DCs enabling such autocrine secretion 44 . Autocrine IL-2 allows for the induction of NGFI-A-binding protein 2 (NAB2) expression by CD8 + T cells, which mediates the suppression of TRAIL expression and allows for the secondary expansion of these cells 44 . Licensed DCs also produce IL-12p70 that acts directly on antigen-specific CD8 + T cells to increase their expression of CD25 (also known as IL-2Rα), rendering these cells more responsive to IL-2 (REFS 43, 46) .
Regulatory CD4 + T (T Reg ) cells can act to modulate IL-2 exposure to effector CD8 + T cells during the priming phase and are necessary for the generation of functional memory CD8 + T cells following immunization [47] [48] [49] [50] ( FIG. 1b) . For example, competitive consumption of IL-2 by T Reg cells can limit the availability of IL-2 to early activated CD8 + T cells, thereby suppressing CD8 + T cell clonal expansion but enhancing the functional responsiveness of memory CD8 + T cells following secondary challenge 47 . Although autocrine IL-2 expression is neces sary for the generation of functional memory CD8 + T cells 45 , prolonged exposure to IL-2 early after immunization promotes their terminal differenti ation 51, 52 . T Reg cells also modulate the maturation state of DCs through lymphocyte function-associated antigen 1 (LFA1; also known as αL integrin)-and cytotoxic T lymphocyte antigen 4 (CTLA4)-mediated regulation of CD80 and CD86 expression, which may influence the ability of DCs to stimulate CD8 + T cells during priming 53, 54 . In addition, T Reg cells regulate the stability of interactions between DCs and CD8 + T cells through suppression of chemokine production by DCs and are crucial for the development of high-avidity effector and memory CD8 + T cells [55] [56] [57] [58] [59] . Additional mechanisms by which T Reg cells can regulate memory formation following infection are discussed in the following section. 25, 67 . This work suggests a model in which TLR ligation induces DC licensing and the secretion of type I IFNs, which subsequently act directly on CD8 + T cells to induce CD25 upregulation and IL-2 production. Thus, infections that induce a strong type I IFN response, such as lymphocytic choriomeningitis virus (LCMV), bypass the requirement for CD4 + T cell help in the primary response, whereas infections such as vaccinia virus that induce a more IL-12-driven response may require CD4 + T cell help 60 . CD4
+ T cell help is dispensable for the primary CD8 + T cell response to influenza virus only when T Reg cells are also absent, which suggests that the method of CD4 + T cell depletion could help to explain the contradictory findings. Conflicting results reported for the same pathogen may also be due to differences in viral inoculum, virulence of recombinant strains or whether T cell receptor-transgenic T cells were transferred before infection 60 . Further work is necessary to fully understand the mechanisms underlying differences in the published literature.
Secondary response. Despite it being appreciated that CD4 + T cells are necessary for CD8 + T cell memory maturation following acute pathogen infection, the mechanism (or mechanisms) by which this help is mediated and which CD4 + T cells are involved are still being clarified 15, 20, 62, [68] [69] [70] . One study showed that CD4 + T cells are required after the priming and expansion phase and that this help can be antigen non-specific 70 . CD4 + T cell help following LCMV infection is independent of CD40-mediated licensing of DCs or CD8 + T cells, and passive transfer of LCMV-specific anti bodies is sufficient to restore a protective memory CD8 + T cell response in the absence of CD40-CD40L interactions through the facilitation of viral clearance 31, 71 . Helpless CD8 + T cells displayed increased expression of T-bet (also known as TBX21), a transcription factor involved in fine-tuning CD8 + effector and memory T cell differentiation, with reduction in T-bet expression restoring the functionality of these cells 72, 73 . In addition, CD4 + T cell help influences the epigenetic state of memory CD8 + T cells, with helpless CD8 + T cells displaying reduced acetylation at the IFNG locus and increased methylation at the IL2 promoter resulting in reduced responsiveness following restimulation 74 . Treatment with a histone deacetylase inhibitor is sufficient to partially restore the responsiveness of helpless CD8 + T cells 75 .
Effector CD4
+ T cells induced following acute pathogen infection display considerable phenotypic and functional heterogeneity that can influence their ability to provide help
. Insight into the specific mechanism (or mechanisms) that underlie CD4 + T cell help was provided by the finding that IL-10, which is normally thought of as an immunosuppressive cytokine, is important for memory CD8 + T cell development. Although normal numbers of memory CD8 + T cells form in the absence of IL-10, the maturation of these cells was impaired, particularly the development of T CM cells [76] [77] [78] . The cellular source of IL-10 that was needed to promote the phenotypic and functional qualities of the memory CD8 + T cells was unclear from these studies. Several cell types including myeloid cells, DCs and T cells can secrete IL-10 following LCMV infection 79, 80 . Interestingly, and somewhat counter-intuitively, we found that T Reg cells act as the relevant source of IL-10 required for memory CD8 + T cell maturation following LCMV infection. In line with the kinetics of CD4 + T cell help identified earlier 70 , T Reg cell-derived IL-10 primarily acted during the contraction and resolution phase to promote memory CD8 + T cell maturation through the suppression of pro-inflammatory cytokine production by DCs 49 (FIG. 2) .
A related study found that T Reg cells influence CD8 + T cell memory maturation through CTLA4-mediated suppression of effector and proliferation programmes in effector CD8 + T cells 50 . So, T Reg cells can promote functional memory CD8 + T cell development and function through many mechanisms.
In addition to this function, T Reg cells can act during the priming phase to suppress the magnitude of the CD8 + T cell response, thereby restricting the number of cells that survive into the memory phase [81] [82] [83] . However, type I IFNs generated early after viral infection can directly inhibit T Reg cell activation and proliferation, facilitating the generation of a robust effector T cell response 84 .
As the levels of type I IFNs wane, T Reg cell expansion occurs; the newly populating T Reg cells display an . T follicular helper cell differentiation is regulated by signal transducer and activator of transcription 3 (STAT3)-signalling cytokines such as IL-6 and IL-21 and is dependent on iterative interactions with cognate dendritic cells and B cells [137] [138] [139] [140] [141] . CD4
+ T cell subsets can be identified through the expression of cell surface markers, such as LY6C, P-selectin glycoprotein ligand 1 (PSGL1), CXC-chemokine receptor 5 (CXCR5) and programmed cell death protein 1 (PD1), and of canonical transcriptions factors T-bet, GATA-binding protein 3 (GATA3), retinoic acid receptor-related orphan receptor-γt (RORγt) and BCL-6, and through the secretion of cytokines such as IFNγ, tumour necrosis factor, IL-4, IL-5, IL-13, IL-17 and IL-21. The considerable plasticity among effector CD4 + T cell subsets in vivo helps to facilitate the generation of a diverse immune response capable of mediating pathogen clearance, promoting the humoral response and restraining immunopathology 130 . Nature Reviews | Immunology 91, 92 . We extended these studies to find that CD4 + T cells are important for the development of airway-homing CD8 + T RM cells following influenza virus infection 93 . Although CD8 + T cells entered the lung in the absence of CD4 + T cell help, they failed to properly localize to the lung airways and had a reduced ability to recruit CD8 + T cells from the circulation and mediate protective immunity following heterosubtypic challenge. Helpless CD8 + T cells also displayed enhanced expression of T-bet, which rendered these cells less responsive to transforming growth factor-β (TGFβ)-mediated induction of CD103, an integrin that is essential for T RM cell maintenance in the tissue 93 . Together, these studies provided a model in which IFNγ-producing CD4 + T cells directed effector CD8 + T cell migration into particular areas of certain mucosal tissues that then facilitated their exposure to signals, such as TGFβ, necessary for their continued maturation into CD103 + T RM cells (FIG. 3b) . T Reg cells also may have a role in the formation of CD8 + T RM cells. In the absence of T Reg cells, reduced numbers of CD8 + T RM cells were retained in the central nervous system (CNS) following infection with West Nile virus. The reduction in T RM cell numbers is associated with decreased amounts of TGFβ in the CNS, suggesting that T Reg cell-dependent modulation of TGFβ levels may be important in driving CD8 + T RM cell formation and retention in mucosal tissues 94 (FIG. 3c) . This finding further supports a new, perhaps paradoxical, role for T Reg cells in providing helper functions as opposed to suppressive functions for the generation of long-term T cell immunity.
CD4
+ T cell help following chronic infection CD4 + T cells have crucial roles in the long-term maintenance of functional CD8 + T cells in many models of chronic viral infection [95] [96] [97] [98] [99] . A central component of CD4 + T cell help in this setting is the secretion of IL-21 (REFS 100,101). IL-21 sensing by CD8 + T cells is necessary for the avoidance of clonal deletion and maintenance of effector activity, even in the presence of CD4 + T cells, through induction of basic leucine zipper transcription factor ATF-like (BATF) 102, 103 . IL-21 production by CD4 + T cells in individuals infected with HIV-1 correlates with CD8 + T cell functionality and viral control, suggesting that this pathway might be an important therapeutic target [104] [105] [106] . Persistence of high antigen levels is a key driver of CD8 + T cell functional exhaustion during chronic viral infection 107 . Therefore, an additional indirect role of CD4 + T cell-derived IL-21 in bolstering the CD8 + T cell response Following acute viral infection, regulatory T (T Reg ) cell expansion is initially suppressed owing to the presence of high levels of type I interferons (IFNs). As type I IFN levels wane, T Reg cell numbers increase, and these cells adopt a more effector-like phenotype that is marked by increased expression of interleukin-10 (IL-10) and cytotoxic T lymphocyte antigen 4 (CTLA4). During the resolution phase of infection, T Reg cell-derived IL-10 acts to suppress the maturation state of dendritic cells (DCs) and limit their production of pro-inflammatory cytokines. T Reg cell expression of CTLA4 acts in a similar manner through modulation of the CD28-CD80 and/or CD28-CD86 signalling axis. Low levels of pro-inflammatory signals allow for the continued maturation of effector CD8 + T cells into functional memory CD8 + T cells. In the absence of T Reg cell-derived IL-10 and/or CTLA4, DCs adopt a more mature phenotype and secrete higher levels of pro-inflammatory cytokines. The enhanced levels of pro-inflammatory cytokines are sensed by effector CD8 + T cells and drive these cells to adopt a more terminally differentiated phenotype, limiting their ability to proliferate and mediate protective immunity upon re-encounter with the pathogen. IL-10R, IL-10 receptor; TCR, T cell receptor; TNF, tumour necrosis factor. during chronic infection may be through promoting viral control. Several effector CD4 + T cell subsets can secrete IL-21 following viral infection, including follicular helper T (T FH ) and T helper 1 (T H 1) cells 108 . Viral persistence promotes the differentiation of T FH cells, which are necessary for the maintenance of the germinal centre response and the continued production of virus-specific antibodies in the face of prolonged high levels of virus replication and immunosuppression 109, 110 . T FH cell-derived IL-21 is also crucial for the germinal centre response, and deficiency in IL-21 results in impaired maintenance of the germinal centre, which is associated with reduced B cell affinity maturation and isotype class switching [111] [112] [113] . Together, these studies suggest that T FH -cell derived IL-21 is needed to promote the virus-specific humoral response, thus allowing for the continued control of viraemia and the prevention of terminal exhaustion.
IL-2 treatment also can enhance CD8 + T cell responses during chronic infection and allows for enhanced control of viral burden 42, 114 . The beneficial effect of such treatment is limited in the absence of CD4 + T cells, which can serve as a source of IL-2 during chronic infection 115 . IL-2 therapy also results in an increase in the number of T Reg cells 115 . T Reg cells adopt an activated phenotype during chronic viral infection and have enhanced expression of molecules related to their suppressive activity, including CTLA4, CD39 (also known as NTPDase 1) and IL-10 (REFS 79,116). Depletion of T Reg cells during chronic infection resulted in a marked expansion of functional CD8 + T cells through a process dependent on CD4 + T cells and the expression of co-stimulatory molecules on DCs 116 . T Reg cell depletion alone was not sufficient to reduce viral burden but did lead to a significant reduction in viral titres when combined with antibody-mediated blockade of programmed cell death 1 ligand 1 (PDL1) 116 . Therefore, in contrast to acute infection, suppression of the maturation state of DCs by T Reg cells during chronic infection serves to dampen long-term effector CD8 + T cell responses. It is important to investigate whether the beneficial effect of IL-2 therapy is enhanced in the absence of T Reg cells.
Similar to chronic infection, the immune response to cancer is marked by the persistence of antigen that can lead to a loss of T cell function 117 . Accordingly, CD4 + T cell help can promote, whereas T Reg cells suppress, the antitumour CD8 + T cell response [118] [119] [120] [121] . CD4 + T cells can enhance the recruitment, proliferation and effector function of CD8 + T cells within the tumour 121, 122 . The secretion of IFNγ induces the expression of chemokines that are necessary to recruit CD8 + T cells to the tumour, whereas the production of IL-2 by tumour-specific CD4 + T cells can promote CD8 + T cell proliferation and expression of granzyme B 121 . CD4 + T cells can also directly suppress tumour growth through IFNγ and cytotoxic functions 123 . Conversely, T Reg cells within the tumour can interact with DCs and suppress the expression of CD80 and CD86, leading to the induction of a dysfunctional state within CD8 + T cells that is marked by high expression of inhibitory receptors and poor effector function 119 . Given that T cell effector functions are highly dependent on glucose and glutamine, T cell-nutrient deprivation by T Reg cells may be another component of immunosuppression observed in the tumour micro environment [124] [125] [126] . Currently, many therapies are aimed at delivering CD4 + T cell help to tumour sites, including vaccinations and adoptive T cell transfer [127] [128] [129] . It is important to learn how CD4 + T cells are involved in the durable responses observed in some patients following immunotherapy treatment.
Concluding remarks and perspective
A temporal model for the function of CD4 + T cells in regulating CD8
+ T cell maturation into distinct subsets that can mediate protective immunity following infection and immunization has begun to emerge (FIG. 4) . During the priming phase, CD4 + T cells, through IFNγ-mediated chemokine induction, license CD8 + T cell entry into mucosal tissues and facilitate their migration into a tissue microenvironment where they can sense the signals necessary for their long-term residence 90, 93 . Effector CD4 + T cells also help to facilitate viral clearance through the induction of an antiviral humoral response, as well as directly through the secretion of effector molecules and cytokines 130 . Rapid viral clearance is important for restricting the degree of exposure of CD8 + T cells to antigen and inflammation, thus preventing functional exhaustion. High levels of type I IFNs present during this stage of infection also restrict T Reg cell expansion and allow for a robust effector T cell response 84 . During immunization and certain infections, CD4 + T cells are also necessary to guide CD8 + T cells towards cognate XCR1 + DCs and to license these cells to provide the signals that enable autocrine secretion of IL-2, thereby promoting robust primary and secondary responses.
During the resolution phase, as the levels of type I IFNs wane, there is an expansion of activated T Reg cell populations. IL-10 secretion by activated T Reg cells can suppress the maturation state of DCs and limit their secretion of + T cells rapidly migrate from the DLN to the lung airways where they mediate the release of chemokines from epithelial cells through secretion of IFNγ. As CD8 + T cells move from the DLN to the lung parenchyma, they upregulate CD69 expression, probably owing to exposure to inflammatory cytokines and antigen. These cells can then migrate towards the chemokine gradient surrounding the airway where they encounter transforming growth factor-β (TGFβ), which subsequently induces the expression of CD103 and suppression of the transcription factor T-bet, thereby promoting the establishment of a lung-resident memory T cell population. For example, our understanding of how CD8 + T cell migration into affected tissues and tumours is regulated by CD4 + T cells mainly relies on analysis that depends on tissue digestion or imaging of fixed samples. As technology improves, it will be important to use intravital imaging to dynamically monitor CD8 + T cell entry and migration within these sites to yield further insight into this process and open up new avenues of research. It is also unclear what role CD4 + T cell help might have in regulating the metabolic programming of CD8 + T cells. Switches in metabolic state have recently been found to be important drivers of CD8 + T cell differentiation and function, so it will be important to understand whether CD4 + T cells are directly or indirectly governing this process 124, 125, [131] [132] [133] [134] . In addition, a comprehensive analysis of the transcriptional and epigenetic alterations in helpless CD8 + T cells that emerge over the course of infection has not been performed and could bolster our understanding of this process. In particular, this type of kinetic approach could inform our understanding of why there seems to be a specific window during infection during which CD4 + T cell help is most needed to promote a CD8 + T cell pool that can mediate protective immunity 49 . As our understanding of the mechanisms underlying CD4 + T cell help grows, it will be important to harness these findings therapeutically to boost vaccine efficacy. Considering the difficulties surrounding previous attempts at developing effective T cell-based vaccines, it may be necessary to modify existing vaccination approaches to more closely mirror the natural response to infection. This may be particularly relevant for vaccines against mucosal viruses, such as influenza virus and HIV, to which it is probably necessary to induce T CM , T EM and T RM cell populations to optimally protect the host. Work is underway to develop vaccines that can drive CD8 + T cells into mucosal sites and expose them to the signals necessary for their continued maintenance in the tissue, similar to the function of CD4 + T cells during mucosal infection 9, 135 . Therapeutic interventions that are designed to suppress inflammatory levels in individuals following vaccination through expansion of T Reg cells or provision of IL-10 may also be a novel approach to bolstering systemic T cell immunity. Individuals suffering from chronic infection have impaired development of protective immunity following vaccination, potentially owing to high levels of bystander inflammation, and they would be an attractive target for this type of intervention 136 . It will also be important to explore the efficacy of combining existing immunotherapies used to treat individuals with chronic infection or cancer with therapies designed to modulate the quality or quantity of CD4 + T cell help. + T cells also license the entry of CD8 + T cell into mucosal tissues and promote viral clearance through the induction of a virus-specific effector CD4 + T cell response and a humoral response. Later in the resolution phase, regulatory T (T Reg ) cell-derived IL-10 facilitates the development of a mature memory CD8 + T cell population and can promote functional quiescence of memory T cells through expression of the inhibitory receptor cytotoxic T lymphocyte antigen 4 (CTLA4). T Reg cells may also modulate transforming growth factor-β (TGFβ) levels in mucosal sites to promote CD103 expression and accordingly regulate tissue-resident memory T cell development. During the memory phase, the CD4 + T cell-dependent immune response allows for continued suppression of viral outgrowth. IFNγ, interferon-γ.
